Insulin Glargine (U-100) Vials and Polatuzumab vedotin
Determining the interaction of Insulin Glargine (U-100) Vials and Polatuzumab vedotin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Polatuzumab Vedotin-piiq
- Insulin Glargine (U-100) Vials-Polio vaccine, inactivated
- Insulin Glargine (U-100) Vials-Poliovirus Vaccine (Inactivated)
- Insulin Glargine (U-100) Vials-Poliovirus vaccine, inactivated Injection
- Insulin Glargine (U-100) Vials-Polivy
- Insulin Glargine (U-100) Vials-Polmon
- Polatuzumab vedotin-Insulin Glargine (U-300) Pens
- Polatuzumab vedotin-Insulin glargine and lixisenatide
- Polatuzumab vedotin-Insulin glargine and lixisenatide Subcutaneous
- Polatuzumab vedotin-Insulin glargine, recombinant Subcutaneous
- Polatuzumab vedotin-Insulin glulisine
- Polatuzumab vedotin-Insulin Glulisine (Cartridges and Pens)